RIPK1 and melanoma: In another study, however, pre-treatment of mice with necrostatin-1 or a novel RIPK1 inhibitor, PK68, significantly suppressed lung metastasis by melanoma cells [146], suggesting that further research is needed to clarify the role of RIPK1 in melanoma progression.